PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality-Reference-Cited by-同舟云学术

PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality

Published:2009-08-14 Issue:5 Volume:126 Page:1121-1131
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

López-Knowles Elena,O'Toole Sandra A.,McNeil Catriona M.,Millar Ewan K.A.,Qiu Min R.,Crea Paul,Daly Roger J.,Musgrove Elizabeth A.,Sutherland Robert L.

Funder

National Health and Medical Research Council of Australia (NHMRC)

Cancer Institute NSW, Petre Foundation, RT Hall Trust

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference52 articles.

1. Oncogenic PI3K deregulates transcription and translation;Bader;Nat Rev Cancer,2005

2. Exploiting the PI3K/AKT pathway for cancer drug discovery;Hennessy;Nat Rev Drug Discov,2005

3. An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer;Stemke-Hale;Cancer Res,2008

4. PIK3CA-activating mutations and chemotherapy sensitivity in stage II-III breast cancer;Liedtke;Breast Cancer Res,2008

5. Exon 20 PIK3CA mutations decreases survival in aggressive (HER-2 positive) breast carcinomas;Lerma;Virchows Arch,2008

Cited by 256 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Canadian real world prospective observational study assessing the impact of hormone therapy ± targeted therapy in the treatment of HR+ HER2- advanced breast cancer;2024-07-23

2. Combination of monensin and erlotinib synergistically inhibited the growth and cancer stem cell properties of triple-negative breast cancer by simultaneously inhibiting EGFR and PI3K signaling pathways;Breast Cancer Research and Treatment;2024-07-03

3. CD74-AKT Axis Is a Potential Therapeutic Target in Triple-Negative Breast Cancer;Biology;2024-06-28

4. Evaluation of Copanlisib in Combination with Eribulin in Triple-negative Breast Cancer Patient-derived Xenograft Models;Cancer Research Communications;2024-06-05

5. mTOR: Its Critical Role in Metabolic Diseases, Cancer, and the Aging Process;International Journal of Molecular Sciences;2024-06-02